T3	Subject 3 17	these patients
T4	Treatment 19 41	long-acting octreotide
T6	Effect 54 74	serious hypoglycemia
T8	Drug 31 41	octreotide
T5	Adverse_event 46 53	trigger
E1	Adverse_event:T5